S&P 500   4,445.04 (-0.09%)
DOW   34,733.07 (-0.09%)
QQQ   371.18 (-0.48%)
AAPL   146.07 (-0.52%)
MSFT   297.47 (-0.70%)
FB   346.93 (+0.28%)
GOOGL   2,830.43 (+0.22%)
TSLA   757.54 (+0.52%)
AMZN   3,402.16 (-0.41%)
NVDA   219.53 (-2.35%)
BABA   145.09 (-4.03%)
NIO   35.43 (-1.61%)
CGC   13.98 (-3.98%)
GE   103.63 (+0.65%)
MU   74.29 (+0.34%)
AMD   105.39 (-0.72%)
T   27.28 (+0.33%)
F   13.85 (+1.02%)
ACB   6.04 (-1.79%)
DIS   175.86 (-0.22%)
PFE   44.23 (+0.09%)
BA   221.60 (+0.23%)
BAC   42.14 (+1.08%)
S&P 500   4,445.04 (-0.09%)
DOW   34,733.07 (-0.09%)
QQQ   371.18 (-0.48%)
AAPL   146.07 (-0.52%)
MSFT   297.47 (-0.70%)
FB   346.93 (+0.28%)
GOOGL   2,830.43 (+0.22%)
TSLA   757.54 (+0.52%)
AMZN   3,402.16 (-0.41%)
NVDA   219.53 (-2.35%)
BABA   145.09 (-4.03%)
NIO   35.43 (-1.61%)
CGC   13.98 (-3.98%)
GE   103.63 (+0.65%)
MU   74.29 (+0.34%)
AMD   105.39 (-0.72%)
T   27.28 (+0.33%)
F   13.85 (+1.02%)
ACB   6.04 (-1.79%)
DIS   175.86 (-0.22%)
PFE   44.23 (+0.09%)
BA   221.60 (+0.23%)
BAC   42.14 (+1.08%)
S&P 500   4,445.04 (-0.09%)
DOW   34,733.07 (-0.09%)
QQQ   371.18 (-0.48%)
AAPL   146.07 (-0.52%)
MSFT   297.47 (-0.70%)
FB   346.93 (+0.28%)
GOOGL   2,830.43 (+0.22%)
TSLA   757.54 (+0.52%)
AMZN   3,402.16 (-0.41%)
NVDA   219.53 (-2.35%)
BABA   145.09 (-4.03%)
NIO   35.43 (-1.61%)
CGC   13.98 (-3.98%)
GE   103.63 (+0.65%)
MU   74.29 (+0.34%)
AMD   105.39 (-0.72%)
T   27.28 (+0.33%)
F   13.85 (+1.02%)
ACB   6.04 (-1.79%)
DIS   175.86 (-0.22%)
PFE   44.23 (+0.09%)
BA   221.60 (+0.23%)
BAC   42.14 (+1.08%)
S&P 500   4,445.04 (-0.09%)
DOW   34,733.07 (-0.09%)
QQQ   371.18 (-0.48%)
AAPL   146.07 (-0.52%)
MSFT   297.47 (-0.70%)
FB   346.93 (+0.28%)
GOOGL   2,830.43 (+0.22%)
TSLA   757.54 (+0.52%)
AMZN   3,402.16 (-0.41%)
NVDA   219.53 (-2.35%)
BABA   145.09 (-4.03%)
NIO   35.43 (-1.61%)
CGC   13.98 (-3.98%)
GE   103.63 (+0.65%)
MU   74.29 (+0.34%)
AMD   105.39 (-0.72%)
T   27.28 (+0.33%)
F   13.85 (+1.02%)
ACB   6.04 (-1.79%)
DIS   175.86 (-0.22%)
PFE   44.23 (+0.09%)
BA   221.60 (+0.23%)
BAC   42.14 (+1.08%)
ASX:UBI

Universal Biosensors Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume10,006 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive UBI News and Ratings via Email

Sign-up to receive the latest news and ratings for Universal Biosensors and its competitors with MarketBeat's FREE daily newsletter.


About Universal Biosensors

Universal Biosensors, Inc., through its subsidiary, Universal Biosensors Pty Ltd, operates as a biosensors company in Australia. The company focuses on the development, manufacture, and commercialization of point-of-use devices for measuring analytes across various industries. It offers SENTIA Wine Analyzer to test Free Sulphur Dioxide; prothrombin time international normalized ratio coagulation test strips; Sentia Free Sulphite test strips; and coagulation testing and calibration services, as well as distributes Siemens' Xprecia Stride Coagulation Analyzer. The company has a license agreement with LifeScan Global Corporation to develop a biosensor strip and a meter to be used for the detection and monitoring of diabetes in animals. Universal Biosensors, Inc. was incorporated in 2001 and is headquartered in Rowville, Australia.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.75 out of 5 stars

Analyst Opinion: 0.0Community Rank: 3.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Universal Biosensors (ASX:UBI) Frequently Asked Questions

What stocks does MarketBeat like better than Universal Biosensors?

Wall Street analysts have given Universal Biosensors a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Universal Biosensors wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Universal Biosensors' earnings last quarter?

Universal Biosensors, Inc. (ASX:UBI) released its quarterly earnings results on Tuesday, April, 30th. The company reported ($0.01) EPS for the quarter.
View Universal Biosensors' earnings history
.

Who are Universal Biosensors' key executives?

Universal Biosensors' management team includes the following people:
  • Mr. John Stewart Sharman M.App.Fin, CA, B Ec, Chief Exec. Officer (Age 55, Pay $507.22k)
  • Mr. Salesh Balak BA, CA, CFO & Company Sec. (Age 52, Pay $571.19k)
  • Mr. Nicholas Bliesner, Head of Operations
  • Ms. Ann Chew, Head of HR & Internal Audit
  • Dr. Ronald Chatelier BSc. (Hons.), Ph.D., Chief Research Scientist (Age 61)
  • Mr. Steven Goeby, Head of Design & Devel.
  • Mr. Luke Cossins, Head of R&D

What is Universal Biosensors' stock symbol?

Universal Biosensors trades on the ASX under the ticker symbol "UBI."

How much money does Universal Biosensors make?

Universal Biosensors has a market capitalization of $0.00 and generates $5.53 million in revenue each year.

How many employees does Universal Biosensors have?

Universal Biosensors employs 60 workers across the globe.

What is Universal Biosensors' official website?

The official website for Universal Biosensors is www.universalbiosensors.com.

Where are Universal Biosensors' headquarters?

Universal Biosensors is headquartered at Rowville, 1 Corporate Ave, MELBOURNE, VIC 3178, Australia.

How can I contact Universal Biosensors?

Universal Biosensors' mailing address is Rowville, 1 Corporate Ave, MELBOURNE, VIC 3178, Australia. The company can be reached via phone at +61-3-92139000.


This page was last updated on 9/24/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.